STAT | Reporting from the frontiers of health and medicine Follow STAT+: Senate-passed BIOSECURE Act would add arrow to Trump’s drug-pricing quiver The Senate has passed legislation that would restrict U.S. pharmaceutical and biotechnology companies from doing business with certain Chinese companies. https://www.statnews.com/2025/10/10/senate-passes-biosecure-act-trump-drug-pricing-china/ statnews.com
